Technical Analysis for AMRN - Amarin Corporation plc

Grade Last Price % Change Price Change
grade C 17.51 0.00% 0.00
AMRN closed unchanged on Monday, March 25, 2019, on 56 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical AMRN trend table...

Date Alert Name Type % Chg
Mar 25 MACD Bearish Centerline Cross Bearish 0.00%
Mar 25 Below Lower BB Weakness 0.00%
Mar 25 Lower Bollinger Band Touch Weakness 0.00%
Mar 25 Oversold Stochastic Weakness 0.00%
Mar 22 Fell Below 50 DMA Bearish 0.00%
Mar 22 New Downtrend Bearish 0.00%
Mar 22 180 Bearish Setup Bearish Swing Setup 0.00%
Mar 22 Outside Day Range Expansion 0.00%
Mar 22 Below Lower BB Weakness 0.00%
Mar 22 Lower Bollinger Band Touch Weakness 0.00%

Older signals for AMRN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids. The company lead product comprises Vascepa, a prescription-only omega-3 fatty acid comprising icosapent ethyl as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It also engages in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland.
Biopharmaceutical Organic Compounds Nutrition Cardiovascular Diseases Cholesterol Low Density Lipoprotein Lipids Hypertriglyceridemia Saturated Fat
Is AMRN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 23.335
52 Week Low 2.35
Average Volume 7,780,594
200-Day Moving Average 12.3273
50-Day Moving Average 18.5074
20-Day Moving Average 20.391
10-Day Moving Average 19.396
Average True Range 1.1855
ADX 35.09
+DI 17.3864
-DI 20.5294
Chandelier Exit (Long, 3 ATRs ) 19.6935
Chandelier Exit (Short, 3 ATRs ) 20.8165
Upper Bollinger Band 23.1933
Lower Bollinger Band 17.5887
Percent B (%b) -0.01
BandWidth 27.485655
MACD Line -0.0877
MACD Signal Line 0.4538
MACD Histogram -0.5415
Fundamentals Value
Market Cap 4.74 Billion
Num Shares 271 Million
EPS -0.31
Price-to-Earnings (P/E) Ratio -56.48
Price-to-Sales 5.87
Price-to-Book 0.00
PEG Ratio -1.74
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.62
Resistance 3 (R3) 18.66 18.33 18.44
Resistance 2 (R2) 18.33 18.05 18.31 18.37
Resistance 1 (R1) 17.92 17.87 18.13 17.88 18.31
Pivot Point 17.59 17.59 17.69 17.57 17.59
Support 1 (S1) 17.18 17.31 17.39 17.14 16.71
Support 2 (S2) 16.85 17.13 16.83 16.65
Support 3 (S3) 16.44 16.85 16.59
Support 4 (S4) 16.40